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these data were corroborated by latency conversion kinetics 
and thermodynamics of copper binding by isothermal titra-
tion calorimetry. These studies identified a copper-binding 
site involving histidines at positions 2 and 3 that confers a 
remarkable stabilization of PAI-1 beyond what is observed 
with vitronectin alone. A second site, independent from 
the two histidines, binds metal and increases the rate of the 
latency conversion.
Keywords Protein structure · Calorimetry · PAI-1 · 
Vitronectin · Somatomedin B domain · Copper
Abbreviations
HDX  Hydrogen–deuterium 
exchange
HDX-MS  Hydrogen–deuterium 
exchange coupled to mass 
spectrometry
IMAC  Immobilized metal affinity 
chromatography
IPTG  Isopropyl 
β-d-1-thiogalactopyranoside
ITC  Isothermal titration 
calorimetry
H2A, H3A, and  
H2AH3A-PAI-1  Mutant form of PAI-1 lack-
ing N-terminal histidines at 
positions 2, 3, or 2 and 3 in 
the amino acid sequence, 
respectively
RCL  Reactive center loop
SMB  Somatomedin B domain
PAs  Plasminogen activators
tPA  Tissue-type plasminogen 
activator
Abstract Components of the fibrinolytic system are sub-
jected to stringent control to maintain proper hemostasis. 
Central to this regulation is the serpin plasminogen activator 
inhibitor-1 (PAI-1), which is responsible for specific and 
rapid inhibition of fibrinolytic proteases. Active PAI-1 is 
inherently unstable and readily converts to a latent, inactive 
form. The binding of vitronectin and other ligands influ-
ences stability of active PAI-1. Our laboratory recently 
observed reciprocal effects on the stability of active PAI-1 
in the presence of transition metals, such as copper, depend-
ing on the whether vitronectin was also present (Thompson 
et al. Protein Sci 20:353–365, 2011). To better understand 
the molecular basis for these copper effects on PAI-1, we 
have developed a gel-based copper sensitivity assay that can 
be used to assess the copper concentrations that accelerate 
the conversion of active PAI-1 to a latent form. The cop-
per sensitivity of wild-type PAI-1 was compared with vari-
ants lacking N-terminal histidine residues hypothesized to 
be involved in copper binding. In these PAI-1 variants, we 
observed significant differences in copper sensitivity, and 
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uPA  Urokinase plasminogen 
activator
VN  Vitronectin
PAI-1  Plasminogen activator 
inhibitor-1
Serpin  Serine protease inhibitor
Introduction
Plasminogen activator inhibitor-1 (PAI-1) is a serine pro-
tease inhibitor (serpin) responsible for controlling blood 
flow, and thus is subjected to strict regulation at the genetic 
as well as protein level [1]. PAI-1 inhibits tissue-type (tPA) 
and urokinase (uPA) plasminogen activators (PAs) [1]. Inhi-
bition of the PAs limits the amount of activated plasmin at a 
site of injury or within the extracellular compartments, and 
in turn controls physiological processes including hemosta-
sis [2], extracellular matrix turnover [3], and cell adhesive/
migratory properties [4, 5]. Removal of PAI-1 results in 
compromised wound healing and mild bleeding states due to 
lack of control of the fibrinolytic components [6, 7], At the 
same time, excessive levels of PAI-1 result in atherosclerosis 
[8], fibrosis in several tissue types [9], inflammation [10], 
metabolic syndrome [11], and cancer [12].
PAI-1 utilizes a solvent-exposed loop characteristic 
of serpins termed the reactive center loop (RCL) shown 
in Fig. 1 [13]. The RCL contains the same scissile bond 
that the PAs target in their natural substrate, plasmino-
gen [13]. The inhibitory mechanism of PAI-1 mirrors 
the process of peptide bond cleavage by serine proteases 
until the final step, in which the acylated RCL inserts into 
the protein body, translocating the protease with a highly 
distorted active site to the opposite pole of the inhibitor 
[14]. Among serpins, PAI-1 is unique due to its inherent 
metastability in the active form [15]. PAI-1 has a half-life 
of approximately 1–2 h, then spontaneously undergoes a 
significant structural rearrangement to an inactive, latent 
form that can no longer inhibit proteases (Fig. 1) [16]. A 
directed sequence of steps accounts for this conversion to 
the latent structure, in which the uncleaved RCL must pass 
through the gate region loops (s3C-s4C, s3B-hG) before 
inserting in between the shutter region strands (s3A and 
s5A) [17–19]. For full RCL peptide insertion to occur, 
helix F (hF) covering the lower part of the shutter must be 
temporarily displaced [20]. An area denoted the flexible 
joint region (hD, hE, s1A) is important for protein–protein 
interactions, most notably with another glycoprotein, vit-
ronectin (VN) [21]. VN binds to PAI-1 with high affinity 
(Kd ~0.1 nM) to localize and stabilize PAI-1 in the active 
form [22, 23].
Several factors influence the rate at which PAI-1 
converts to the latent form, including ligands [24, 25], 
post-translational modifications [26], pH [27], and pro-
tein dynamics [28, 29]. Protein dynamics play a role in 
the latency process, whereby conditions that stabilize 
PAI-1 decrease protein dynamics, and those that destabi-
lize PAI-1 increase protein dynamics [29]. Furthermore, 
hydrogen–deuterium exchange mass spectrometry (HDX-
MS) has revealed local unfolding events within the hydro-
phobic core of PAI-1 that are hypothesized to be on the 
path to the latent state [30]. Ligands such as VN [24], 
antibodies [31], and RNA aptamers [25] stabilize PAI-1 to 
varying degrees; these ligands also restrict PAI-1 dynam-
ics [28, 32].
Metal ion ligands such as copper have a particularly inter-
esting effect on the stability of PAI-1, observed in its rate 
of latency conversion in the presence and absence of VN, 
Fig. 1  PAI-1 exists in an active and latent conformation. The struc-
ture of the active form of plasminogen activator inhibitor-1 (PAI-
1) (PDB entry 3Q02) and the latent form of PAI-1 (PDB entry 
1DVN)  are shown. The reactive center loop (RCL) (red) acts as 
bait for proteases in the active form where it is solvent-exposed; 
it is inserted into central β-sheet A in the latent form. Several steps 
in the mechanism of the transition to the latent form have been pro-
posed [31], and it appears that local unfolding within key regions is 
involved [30]. The shutter region (teal) expands, and the gate region 
loops (blue) rearrange during the RCL insertion that occurs during 
the latency conversion. Helix F (purple) may be displaced temporar-
ily during unfolding of the hydrophobic core and/or rearrangement in 
the bottom half of the shutter when the RCL is added as an additional 
strand in the central β-sheet. The flexible joint region (green) is an 
important site for PAI-1 protein–protein interactions, including bind-
ing of the somatomedin B (SMB) domain [22]. The nomenclature 
for secondary structure is as follows: hA  −  hI are α-helices A  −  I, 
respectively; s1A is strand 1 of β-sheet A, s6B is strand 6 of β-sheet 
B, etc. The structure and location of histidines 2 and 3 are shown in 
orange for each view of the active or latent form of PAI-1
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as well as the isolated N-terminal somatomedin B (SMB) 
domain [28]. Copper binds to PAI-1 with high affinity (Kd 
~0.09 μM), resulting in significant acceleration in the rate 
of latency conversion [33]. However, when bound to both 
VN (or the isolated SMB domain) and copper, PAI-1 is sta-
bilized to an even greater extent than observed upon binding 
of VN or SMB alone [24]. These unusual metal effects have 
not been observed with any other serpins. HDX-MS experi-
ments determined that addition of copper destabilizes PAI-1 
by localized increases in protein dynamics [29], whereas the 
combination of copper and SMB binding results in decreases 
in dynamics within the same regions of PAI-1 [29].
Several parallels can be drawn comparing disease states 
due to dysregulation of PAI-1 and those due to copper 
homeostasis. Physiological copper concentrations are under 
stringent temporal and spatial control within and outside 
cells. Copper is a required cofactor for the function of many 
proteins, but in excess is highly toxic [34, 35]. Copper is 
integral to wound healing and angiogenesis, as its removal 
retards both processes [36]. Copper is known to be involved 
in vascular permeability, platelet–endothelial interactions, 
and the activation of smooth muscle cells [37]. On the other 
hand, elevated levels of copper can lead to oxidative dam-
age including double strand DNA breaks, lipid peroxidation, 
and protein oxidation [34]. Although virtually all circulat-
ing copper is bound to proteins, namely ceruloplasmin or 
serum albumin [38], the concentrations of copper and PAI-1 
within several biological compartments are such that physi-
ologically relevant interactions can impact PAI-1 function 
[38–41].
This study investigates the molecular basis for copper 
effects on PAI-1 stability and overall function. Previous 
studies involving surface plasmon resonance with a nickel-
NTA chip, stopped-flow binding measurements, and HDX-
MS support a specific metal ion binding site within PAI-1 
[24, 29, 33]. Several unanswered questions remain regard-
ing copper effects on PAI-1: Where do copper ion(s) bind 
to PAI-1? What is the affinity and stoichiometry of PAI-
1-copper interactions? How does copper increase PAI-1 
stability (i.e., delay PAI-1 latency) when bound to PAI-1 
in tandem with VN or the SMB domain? Alternatively, 
how does copper binding in the absence of vitronectin 
increase the rate of PAI-1 latency conversion? To investi-
gate these questions, we have targeted histidine residues 
using site-directed mutagenesis and have compared cop-
per binding and functional effects with wild-type PAI-1. 
We have utilized isothermal titration calorimetry (ITC) 
and gel-based assays to characterize metal-binding prop-
erties. Furthermore, we have used activity measurements 
and rates of latency conversion to determine whether the 
targeted histidines coordinate copper at a site that leads to 
the rapid loss of activity in PAI-1.
Materials and methods
Protein expression, purification and activity 
measurements
Wild-type PAI-1 and variants were cloned in a pET24d 
expression plasmid and expressed in Rosetta 2 DE3 pLysS 
E. coli cells. PCR-based site-directed mutagenesis was 
used to introduce mutations to the triplet codons encod-
ing for histidines 2 and 3 and tryptophan 175 of PAI-1 
to create H2A, H3A, H2AH3A, and H2AH3AW175F 
PAI-1 variants. Each of the mutations was confirmed by 
DNA sequencing. Wild-type PAI-1 and variant constructs 
were transformed into the expression cell line, grown, 
and expressed using established protocols [24]. A stand-
ard three-step purification scheme was employed [24], but 
with some notable adjustments for the variants, as fol-
lows. Cell lysis and the initial step of ion exchange chro-
matography were performed at pH 5.5 due to the change 
in pI when the N-terminal histidines were absent. This 
resulted in improved binding to the sulfopropyl column, 
and improved separation within the elutions. In addition, 
the N-terminal histidines are required for wild-type PAI-1 
binding to an immobilized metal affinity chromatography 
column (IMAC). Since variants lacking the histidines 
failed to bind to an IMAC column, we used hydropho-
bic interaction chromatography with separation on a Phe-
nyl Sepharose column instead. PAI-1 was dialyzed into 
20  mM  KH2PO4, 600  mM  (NH4)2SO4, 1  mM EDTA, 
pH 7 overnight, loaded onto the Phenyl Sepharose col-
umn, and eluted with a linear reverse  (NH4)2SO4 gradi-
ent (600–10 mM). In the final step of the purification, the 
protein was concentrated, and loaded on a size exclusion 
chromatography column as previously described [24].
The activity of wild-type and variant forms of PAI-1 was 
measured using standard assays [24]. PAI-1 was mixed with 
tPA at varying molar ratios ranging from 0.25 to 4 (PAI-
1:tPA). The inhibitory capacity of PAI-1 was measured in 
a gel-based assay, wherein the PAI-1/tPA complex at each 
molar ratio was monitored and quantified by densitometry. 
PAI-1 inhibition of proteases was also measured in a kinetic 
assay in which the tPA-substrate (Spectrozyme tPA, Sekisui 
Diagnostics) was added to the mixture containing PAI-1 and 
tPA. Cleavage of the p-nitroanaline group of Spectrozyme 
tPA was detected by absorbance at 405 nm, allowing for the 
measurement of tPA activity over time at each molar ratio 
of PAI-1:tPA. Purified active wild-type PAI-1 fully inhibits 
tPA with 1.25 molar equivalents of PAI-1. Latent PAI-1 was 
generated by dilution in buffer (50 mM sodium phosphate, 
300 mM NaCl, 1 mM EDTA, pH 6.25) to a 5 μM concentra-
tion, and incubation at 37 °C with light stirring for 6 days. 
The aforementioned activity measurements were performed 
to confirm that no active PAI-1 remained in the mixture.
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Metal ion titration gel assay
To determine the Cu(II) concentrations required to induce 
accelerated PAI-1 latency, we used a gel-based metal ion 
titration assay. Serial dilutions of  CuSO4 were prepared, 
resulting in final Cu(II) concentrations ranging from 5 to 
1000 μM. Addition of copper resulted in a drop of as much 
as 0.2 pH units, so the solution was readjusted using NaOH. 
Incubation with metal was initiated by adding PAI-1 at a 
final concentration of 4 μM and maintaining the mixture 
at 37 °C in 50 mM MOPS, 100 mM  (NH4)2SO4 pH 7.4 for 
30 min. After the 30-min incubation, PAI-1 was mixed in 
a 1:1 ratio with single-chain tPA (Molecular Innovations). 
Three control samples (PAI-1, tPA, and PAI-1/tPA) were 
also tested in which copper is not included. Non-reducing 
SDS-PAGE dye was added to each sample, followed by boil-
ing for 10 min prior to loading on the gel. The free/latent 
PAI-1, free tPA, and PAI-1/tPA complex in each sample 
were separated and visualized by SDS-PAGE electropho-
resis in a 4–12% gradient gel (Invitrogen). Samples were 
subjected to electrophoresis at 150 V for 75 min. SDS-PAGE 
gels were stained with Coomassie blue dye overnight, fol-
lowed by three destaining steps of 90 min in deionized water 
containing 30% methanol and 7.5% glacial acetic acid. Gel 
pictures were captured using a ChemiDoc XRS molecular 
imager (Biorad), and gel band densitometry of the PAI-1/
tPA complex bands was performed using Imagelab (Biorad). 
The band intensity of each sample was normalized to 100% 
with an untreated PAI-1/tPA complex sample, and to 0% 
using the gel background. Averages and error were generated 
(n = 2) for each assay, and the normalized band intensities 
were plotted as a function of the logarithm of total cop-
per concentration. The midpoint copper concentration for 
wild-type PAI-1 or each variant was extrapolated from the 
semi-log plots as the copper concentration at which 50% of 
PAI-1/tPA complex was observed; this measurement was 
used as an expression of relative metal “sensitivity” of the 
various forms of PAI-1.
Stability kinetics assays
To measure the half-life of PAI-1 latency conversion, stabil-
ity assays were performed. PAI-1 at 0.1 μM was incubated 
in 50 mM MOPS, 100 mM  (NH4)2SO4, 0.1 mM EDTA pH 
7.4 at 37 °C. At specific time points, aliquots of PAI-1 were 
taken and mixed with 0.1 μM two-chain tPA (Molecular 
Innovations), in 50 mM MOPS, 100 mM  (NH4)2SO4, 2 mM 
EDTA, 1% bovine serum albumin, pH 7.4. Individual sam-
ples were analyzed in 96-well plates by mixing with a final 
concentration of 1 mM Spectrozyme tPA substrate (Sekisui 
Diagnostics). The reaction was monitored over a 5-min time 
period via tPA substrate cleavage at the p-nitroanaline group 
that absorbs at 405 nm. This measurement was conducted in 
triplicate for multiple incubation times that covered a range 
up to ten times the PAI-1 half-life. The averages of the reac-
tion slopes were entered into GraphPad Prism Software for 
analysis. The reaction slopes were plotted as a function of 
PAI-1 incubation time to calculate tPA activity over time. 
Taking the negative slope and normalizing the data (100% 
at t = 0; 0% at the lower baseline time points) yielded the 
normalized PAI-1 activity as a function of PAI-1 incubation 
time. To determine the rate of latency conversion (klat), the 
data were fit to the exponential decay equation xt = x0e−kt, 
where xt is the amount of active PAI-1 at a given time, x0 is 
the amount of PAI-1 at time 0, k is the rate of latency conver-
sion, and t is time. The half-life of latency conversion was 
determined as ln(2) k−1. For assays involving copper, PAI-1 
was incubated in the same buffer with 215 μM  CuSO4 added. 
The buffer was corrected for pH change due to copper addi-
tion with NaOH. For assays involving the SMB domain, a 
1:2 PAI-1:/SMB complex was formed prior to incubation at 
37 °C or copper addition. Controls confirmed that there was 
no effect of copper directly on tPA activity [i.e., substrate 
cleavage in the presence of copper was the same as in the 
absence of metal].
Isothermal titration calorimetry
Isothermal titration calorimetry (ITC) was used to deter-
mine the thermodynamic parameters associated with Cu(II) 
interactions with PAI-1. Active and latent forms of wild-type 
and variants of PAI-1 were dialyzed into 100 mM MOPS, 
250 mM  (NH4)2SO4 at 10 °C for 2 h. Because of the rela-
tive instability of the H2AH3A variant of PAI-1, our stud-
ies on H2AH3A PAI-1 utilized a variant that contained an 
additional mutation, W175F. The W175F switch is a well 
characterized substitution used to stabilize the active form 
of PAI-1 during purification and to ensure that a significant 
amount of latent H2AH3A PAI-1 did not accumulate during 
the ITC experiment [42]. Residue 175 is not proximal to the 
N terminus and is not involved in metal ion coordination or 
its subsequent effects on PAI-1 stability. Copper solutions 
were prepared by diluting  CuSO4 into the matched dialysate 
buffer. The copper stock concentration was verified using 
atomic absorbance spectroscopy, and the pH corrected to 7.4 
at 10 °C using NaOH. Twenty micromolar PAI-1 (2.2 mL 
total volume) and copper solution (4 mL) were degassed 
under vacuum for 10 min at 5 °C prior to loading into the 
(Malvern) MicroCal VP-ITC. The PAI-1 solution was loaded 
into the ITC cell (1.394 mL), and the copper solution was 
loaded into the ITC syringe. The reference and experimen-
tal ITC cells were equilibrated to 10 °C prior to the start 
of the experiment. After a preliminary injection of 2 µL, 
each additional injection consisted of a 4 µL injection at 
120 or 240 s intervals. Experiments were performed at least 
in duplicate. Control experiments measuring dilution heats 
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were performed in which the copper solution was injected 
into buffer. The data were baseline corrected using NIT-
PIC software (University of Texas, Southwestern), and fit to 
either a single-site or two-site non-symmetric binding model 
in SEDPHAT (National Institutes of Health). The data and 
fits were represented using GUSSI software (University of 
Texas, Southwestern).
Results
PAI‑1 variants exhibit altered metal sensitivities
The N terminus of PAI-1 comprises a consensus copper 
binding motif similar to sites that have been characterized 
in serum albumin [43, 44], superoxide dismutase [45], and 
prion protein  (PrPc) [46, 47]. This motif contains two his-
tidines, H2 and H3, which are thought to be involved in 
binding copper. To test for differences in copper binding, we 
generated three variants in which the N-terminal histidines 
were replaced with alanine residues, denoted as H2A, H3A, 
and H2AH3A PAI-1. Whereas wild-type PAI-1 can be puri-
fied using an immobilized metal affinity column [24], vari-
ants lacking these histidines did not bind to a nickel-charged 
metal affinity column, providing direct evidence that these 
residues are assessable and can coordinate metal ions.
While this result clearly establishes that a metal-binding 
site exists near the N terminus of PAI-1, the key question 
is to determine whether copper binding effects the transi-
tion between active and latent forms of PAI-1. Initially, a 
gel-based copper sensitivity titration assay was developed 
to determine the copper concentrations that invoke an accel-
erated rate of latency conversion on PAI-1. For this assay, 
PAI-1 samples were incubated with Cu(II) concentrations 
of 5–1000 μM for 30 min, and then mixed with tPA. The 
samples were separated by non-reducing SDS-PAGE. After 
staining, the band intensities of the PAI-1/tPA complex at 
each copper concentration were quantified using gel den-
sitometry. At low concentrations of Cu(II), PAI-1 exhib-
its robust complex formation with tPA, indicating that it 
remains in an active form (Fig. 2a). At intermediate copper 
concentrations, there is clearly a mixture of inactive PAI-1 
and the PAI-1/tPA complex, and at high metal concen-
trations, all PAI-1 is latent and no PAI-1/tPA complex is 
observed. The data yield a sigmoidal curve in a semi-log 
plot, in which the midpoint of the transition represents the 
effective concentration of copper that accelerates the latency 
transition (Fig. 2b). The midpoint in the curve for wild-
type PAI-1 is approximately 150 μM Cu(II) and serves as a 
benchmark “sensitivity” for comparison to variants lacking 
the hypothesized copper binding residues (Table 1). This 
result indicates considerably weaker “sensitivity” in pro-
moting PAI-1 latency compared to the affinity previously 
estimated for copper binding to PAI-1 using stopped-flow 
methods (Kd ~90 nM) [33], which presented a discrepancy 
that was investigated further.
A variant lacking the putative copper-binding residues 
that promote latency would exhibit decreased sensitivity 
compared with wild-type PAI-1, and would require higher 
Cu(II) concentrations to accelerate PAI-1 latency. Thus, if 
copper coordination by the histidine residues accounts for 
the accelerated rate of PAI-1 latency, then we predict that 
the copper sensitivity of these variants would be decreased. 
In contrast, we observed the opposite effect, in which vari-
ants lacking the N-terminal histidines are more sensitive to 
copper compared with wild-type PAI-1 (Fig. 2b). Each of 
the single variants (H2A, H3A) as well as the double variant 
(H2AH3A) of PAI-1 required lower Cu(II) concentrations to 
induce latency, with midpoints in the sensitivity curves of 
approximately 20 μM Cu(II) (Table 1). This unusual obser-
vation indicates that the accelerated latency of PAI-1 in the 
presence of copper is not due to binding to the N-terminal 
histidines. This result also points to the possibility of multi-
ple metal-binding sites with different affinities and different 
effects on the latency transition.
A caveat should be noted because these gel titrations are 
not equilibrium measurements and the “sensitivities” are not 
simple binding constants. Instead, this assay captures points 
across a time course with samples that contain a mixture of 
free PAI-1 and the PAI-1-copper complex. At the incuba-
tion time of 30 min, a mixture of active and latent PAI-1 
is present, with copper-bound and copper-free portions 
of each form, as determined by the Kd for copper binding 
and t1/2 values for latency of PAI-1 and the PAI-1-copper 
complex. Because PAI-1-copper complexes may have dif-
ferent half-lives for the latency transition [24], wild-type 
and variant forms of PAI-1 can be reliably compared with 
this method only when the t1/2 values of the copper-bound 
and copper-free species are similar for the wild-type and 
engineered forms of PAI-1. Fortunately, because the H2A 
and H3A amino acid substitutions did not influence latency 
conversion kinetics, we could directly compare the copper 
sensitivities among these variants of PAI-1.
SMB domain binding dampens copper sensitivity 
of PAI‑1
The SMB domain of VN binds within the flexible joints 
region of PAI-1, resulting in a modest stabilization of the 
active form [21, 24]. Using the gel-based copper titration 
assay, we tested for the effect of SMB binding to PAI-1 on 
the copper sensitivity range for accelerated latency. We 
expected that the formation of the PAI-1/SMB complex 
would lead to decreased copper sensitivity, based on the 
stabilizing effects of SMB binding in the absence of copper 
ions. Wild-type PAI-1 combined with the SMB domain was 
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indeed less sensitive to copper, demonstrated by a midpoint 
in the gel titration assay of approximately 200 μM Cu(II) 
(Fig. 3; Table 1). Prior work has established that the SMB 
domain does not interact with copper [29], so the sensitiv-
ity measured in this assay is solely due to copper binding to 
PAI-1. For comparison, we also tested H2AH3A PAI-1 com-
bined with the SMB domain, and observed a similar copper 
sensitivity. While these results represent a modest decrease 
in copper sensitivity upon binding of SMB to wild-type PAI-
1, they reveal a much more significant decrease for H2AH3A 
PAI-1. The SMB domain exhibits high affinity binding to 
PAI-1 (Kd ~1 nM) [21], and the micromolar concentrations 
of proteins used in these assays are well in excess of the Kd. 
Although it is possible that there are somewhat different 
Fig. 2  Copper titration gel assay for wild-type PAI-1. a Equimolar 
mixtures of PAI-1 and tissue-type plasminogen activator (tPA) were 
prepared after 30  min incubations of PAI-1 with Cu(II) at a wide 
range of concentrations (5–1000 μM, total). Lane 1 contains a molec-
ular ladder, lanes 2–4 are controls in which PAI-1, tPA, and PAI-1/
tPA, respectively, were incubated without Cu(II). Each subsequent 
lane contains PAI-1/tPA mixtures incubated with varying Cu(II) con-
centrations, as indicated. Densitometry of the PAI-1/tPA complex 
(series of bands above the 100 kDa band) within the gel was quanti-
fied using ImageLab. PAI-1 incubated without copper (100%) (lane 
3) and gel background (0%) were used to normalize each data point 
as a percentage. b PAI-1/tPA complex formation is plotted as a func-
tion of the total Cu(II) concentration. The metric for comparison of 
wild-type PAI-1 to PAI-1 variants is taken as the midpoint in cop-
per concentration (“sensitivity”) for which 50% PAI-1/tPA complex 
is observed in the densitometry data. Equimolar mixtures of PAI-1 
and tPA were prepared after 30 min incubations of PAI-1 with vary-
ing Cu(II) concentrations (10–1000  μM, total) in 50  mM MOPS, 
100 mM  (NH4)2SO4 pH 7.4 at 37 °C. Gel densitometry of the PAI-1/
tPA complex was quantified using ImageLab. The band intensity of 
each sample was normalized to 100% with an untreated PAI-1/tPA 
complex sample, and to 0% using the gel background. The percent 
of PAI-1/tPA complex formation is plotted as a function of the total 
Cu(II) concentration. Wild-type and H2AH3A PAI-1 are represented 
by inverted triangles and circles, respectively. Experiments were per-
formed in duplicate
Table 1  Copper sensitivities of wild-type and variant forms of PAI-1 
determined from gel titration assays









Wild-type + 250 mM  (NH4)2SO4 >1000
H2AH3A + 250 nM  (NH4)2SO4 >1000
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binding affinities for wild-type and H2AH3A PAI-1, the 
similar dramatic effects observed in this gel-based assay 
indicate that both are fully saturated with SMB under these 
conditions. Since binding of the SMB domain alters latency 
kinetics independent of copper effects, comparisons with 
these data alone are to be taken with caution in this non-
equilibrium assay. Nonetheless, it is clear that binding of 
the SMB domain to both wild-type PAI-1 and the H2AH3A 
variant dampens sensitivity to copper so that differences in 
the rate of the latency transition that arise due to the histi-
dine replacements are not observed.
Copper stabilizes the PAI‑1/SMB complex 
through binding to the N‑terminal site
To determine how the binding of copper to N-terminal his-
tidines affects the rate of PAI-1 latency, we measured the 
latency conversion kinetics of these variants in the pres-
ence and absence of copper and the SMB domain (Fig. 4; 
Table 2). We first reproduced our previous studies on wild-
type PAI-1, but instead used a MOPS buffer system, which 
offers the benefit of decreased Cu(II)–buffer interaction 
compared with Tris buffer used previously [24]. Wild-type 
PAI-1 remains in the active form for a half-life of 70 min in 
the MOPS buffer. Ligand binding in MOPS buffer imparts 
the same effects on PAI-1 as in Tris buffer; thus wild-type 
PAI-1 in the presence of Cu(II) (215 μM) undergoes latency 
significantly faster, with a half-life of 20 min. As observed 
previously, wild-type PAI-1 is modestly stabilized by incu-
bation with the SMB domain of VN, with a half-life for the 
latency conversion of 125 min. In the presence of copper 
and the SMB domain, PAI-1 is further stabilized, with a 
half-life of 170 min. 
Next, we tested the H2AH3A PAI-1 variant under the 
same conditions to assess the role of copper binding to these 
residues in the PAI-1 latency conversion (Fig. 4; Table 2). 
We measured the rate of latency of the H2AH3A variant 
alone to determine how the N-terminal histidine substitu-
tions themselves influence the latency transition independent 
of copper effects. In these assays, H2AH3A PAI-1 has a half-
life of latency conversion of 74 min, which is not statistically 
different from wild-type PAI-1, indicating that the introduc-
tion of these amino acid substitutions has no intrinsic effect 
on the rate of the latency transition in PAI-1. In addition, 
H2AH3A PAI-1 is destabilized in the presence of copper, 
with a half-life for the latency conversion of 6 min, a shorter 
half-life than observed with wild-type PAI-1 bound to cop-
per. This more pronounced rate of acceleration induced by 
copper binding to the variant compared to wild-type PAI-1 
Fig. 3  Copper titration comparing wild-type PAI-1 versus H2AH3A 
PAI-1. Equimolar mixtures of PAI-1 and tPA were prepared after 
30  min incubations of PAI-1 with varying Cu(II) concentrations 
(10–1000 μM, total) in 50 mM MOPS, 100 mM  (NH4)2SO4 pH 7.4 
at 37 °C. Gel densitometry of the PAI-1/tPA complex was quantified 
using ImageLab. PAI-1 incubated without copper (100%) and gel 
background (0%) were used to normalize each data point as a per-
centage. The percent of PAI-1/tPA complex formation is plotted as 
a function of the total Cu(II) concentration. Wild-type and H2AH3A 
PAI-1 are represented by triangles and circles, respectively. Experi-
ments were performed in duplicate
Fig. 4  Effects of copper and/or SMB binding on stability kinet-
ics measurements of wild-type and H2AH3A PAI-1. Wild-type 
or H2AH3A PAI-1 were incubated at 0.1  μM in 50  mM MOPS, 
100 mM  (NH4)2SO4, 0.1 mM EDTA, pH 7.4 at 37  °C. Four condi-
tions were tested: PAI-1 alone (white bars), PAI-1 + 215 μM Cu(II) 
(black bars), PAI-1 + SMB domain (gray bars), and PAI-1 + SMB 
domain + Cu(II) (checkered bars). At various time points, PAI-1 is 
mixed with 0.11  μM tPA to react with all PAI-1 remaining in the 
active form. tPA activity is measured by addition of 1  mM (final) 
Spectrozyme tPA substrate and the absorbance of substrate cleavage 
is monitored at A405 for 5 min. PAI-1 inhibitory activity is plotted 
versus incubation time and fit to an exponential decay function to 
determine the rate of latency transition. Experiments were performed 
in triplicate
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agrees well with the increased copper sensitivity of the 
H2AH3A variant observed in the gel titration assay. This 
result clearly indicates that a second metal-binding site 
remains in the H2AH3A variant of PAI-1 and suggests that 
this additional site is responsible for the accelerated latency 
conversion. Furthermore, since the half-life for the latency 
transition is actually shorter with the H2AH3A PAI-1 vari-
ant, the increased latency differential for this variant relative 
to wild-type PAI-1 points to a potential stabilizing role of 
copper binding to the N-terminal histidines.
Based on results from the gel titration assay (Fig. 2b), 
we hypothesized that copper binding to the N-terminal his-
tidines is the source of the enhanced stabilization observed 
when copper is incubated with the PAI-1/SMB complex. 
Whereas the copper titration gel assay with the H2AH3A 
PAI-1 variant indicated that metal binding to these two his-
tidines was not the interaction that promotes that latency 
conversion, the assay with the H2AH3A PAI-1/SMB com-
plex in fact revealed a pronounced decrease in sensitivity 
equivalent to that observed with the wild-type PAI-1/SMB 
complex. Consistently, latency conversion kinetics indicated 
that H2AH3A PAI-1 bound to SMB domain is stabilized 
to the same extent as wild-type PAI-1, with a half-life of 
latency conversion of 125 min (Fig. 4; Table 2). Interest-
ingly, however, the H2AH3A PAI-1/SMB complex was not 
further stabilized compared to wild-type PAI-1 by the bind-
ing of copper, with a half-life of latency conversion of only 
89 min. This result stands in contrast to observations of the 
wild-type PAI-1/SMB complex behavior and supports our 
hypothesis, indicating that the enhanced stabilization of the 
PAI-1/SMB complex is imparted through copper binding to 
the N-terminal histidines of PAI-1. Thus, one of the most 
unusual and striking features we observed in our metal stud-
ies with PAI-1, i.e., that copper binding concurrently with 
the SMB domain yields a highly stable form of PAI-1 that 
converts to latency more slowly than with the SMB domain 
alone [24, 29, 33], can be attributed to metal coordination 
by these N-terminal histidines.
ITC identifies differences in Cu(II) interactions 
with active, latent and variant forms of PAI‑1
Isothermal titration calorimetry (ITC) proved to be an 
important tool for investigating the thermodynamic char-
acteristics of Cu(II) binding to PAI-1. This method offers 
the advantage of providing a full thermodynamic charac-
terization for the interaction, with affinity and stoichiometry 
explicitly determined, along with binding enthalpies. In the 
ITC experiments, copper was titrated from a stock solution 
via small injections into a thermal cell containing PAI-1, 
and the power needed to maintain the sample temperature 
was measured. To maintain the active form of PAI-1 over 
the time course of the experiment, we lowered the experi-
mental temperature to 10 °C, and increased the  (NH4)2SO4 
concentration to 250 mM. The increased  (NH4)2SO4 protects 
against non-specific metal ion effects, and was shown in gel 
titration assays (Figure 1S) to render PAI-1 relatively insen-
sitive to metal effects on the latency transition. It should be 
noted that the PAI-1 latency transition itself results in no 
observable heat changes in control ITC experiments [48].
Titrations of active wild-type PAI-1 with Cu(II) rang-
ing up to 650–800 μM were performed and the data were 
subject to global fitting analysis. We observed one sharp 
transition with an n value of 1.2 in all cases, so the data 
were fit to a single-site binding model. Fitting of replicate 
data yielded an average Kobs value of 5.4 × 107  M−1 and 
ΔHobs = −16.2 kcal mol−1 (Fig. 5a, Figure 2S; Table 3). 
This corresponds to an effective Kd = 19 nM, where the 
Kd = 1/Kobs, and averages for ΔGobs and −TΔSobs equal to 
−10.0 and 5.9 kcal mol−1, respectively. These results agree 
well with prior analyses of PAI-1-Cu(II) binding using 
stopped-flow kinetics that determined a Kd of ~ 90 nM [33], 
and give evidence that copper binding to the active wild-
type PAI-1 complex is driven by a highly favorable change 
in enthalpy with a slightly unfavorable change in entropy 
penalty. By contrast, latent wild-type PAI-1 binds Cu(II) 
with two distinct binding transitions, one tight binding tran-
sition accompanied by a significantly weaker one. Global fits 
to multiple data sets indicated that latent PAI-1 binding of 
Cu(II) fits best to a two-site non-symmetric binding model, 
yielding average Kobs terms of 2.4 × 107 and 3.4 × 104 M−1, 
and ΔHobs terms of −12.0 and −11.2 kcal mol−1 for the 
high and low affinity binding sites, respectively (Fig. 5b, 
Figure 3S; Table 3). These parameters correspond to average 
Kd values of 42 nM and 30 μM for the high and low affinity 
sites, respectively. The high affinity Cu(II) binding event in 
latent wild-type PAI-1 shows similar free energy to that in 
the active PAI-1 described above, although the enthalpic and 
entropic contributions are different compared with the site 
in the active form. Interestingly, the weaker binding site has 
Table 2  Kinetic properties for 
copper binding to wild-type and 
H2AH3A PAI-1
PAI-1 variant t1/2 for latency 
conversion, min
t1/2 for latency con-
version [+Cu(II)], 
min
t1/2 for latency 
conversion (+SMB), 
min
t1/2 for latency conver-
sion [+Cu(II), +SMB], 
min
Active WT 70.7 (±3.6) 19.4 (±0.8) 126.2 (±4.3) 170.9 (±2.1)
Active H2AH3A 72.7 (±5.6) 6.2 (±1.0) 125.0 (±1 10.0) 89.2 (±6.7)
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a similar ΔHobs term to the high affinity site, yet its −TΔSobs 
term is more destabilizing, which effectively weakens the 
Cu(II) binding affinity to this site (Table 3). The observed 
thermodynamic parameters are a good benchmark for com-
parison within this study, but further analysis and decon-
volution of the data from these complex ion equilibria are 
required to identify the origins of these changes. 
For comparison, the PAI-1 variant housing the H2AH3A 
substitutions was also studied via ITC. As anticipated, 
Cu(II) titrations on active and latent forms of H2AH3A 
PAI-1 revealed significant differences compared to wild-
type PAI-1 binding of copper. Only a single binding event 
was observed for both latent and active forms of this variant. 
Superficially, this binding event resembles the weak second 
binding event observed in the latent wild-type PAI-1. The 
thermodynamic parameters extracted from the Cu(II) bind-
ing isotherm of the active H2AH3A PAI-1 were an average 
Kobs = 3.4 × 104  M−1 and ΔHobs value of −35.8 kcal mol−1 
(Fig. 5c, Figure 4S; Table 3). This corresponds to an average 
Kd value of 30.5 μM. This value agrees well with the gel 
assay result in which the PAI-1 “sensitivity” midpoint value 
for the latency conversion was 20 μM (Fig. 2b), which is 
similar to the affinity the weak binding site in the latent 
wild-type protein. Although we have good faith in the accu-
racy of the Kobs and ΔGobs terms from this series of ITC 
experiments, the ΔHobs term reported here is likely inac-
curate [49]. The ΔHobs term is primarily determined from 
the first injections of the experiment, and when the affinity 
of this binding isotherm is low there is limited curvature in 
the isotherm, which leads to an inaccuracy in the measured 
enthalpy term. Additional experiments are required to assess 
the impact of the ΔHobs for this system. The absence of the 
tight binding event within H2AH3A PAI-1 suggests that the 
higher-affinity site can be attributed to the N-terminal histi-
dines of PAI-1. The latent H2AH3A PAI-1 exhibits similar 
copper binding compared to the active H2AH3A variant. 
Latent H2AH3A PAI-1 binds Cu(II) with a single binding 
event, with an average Kobs = 6.4 × 104 M−1and ΔHobs value 
Fig. 5  Isothermal titration calorimetry of active, latent and variant 
forms of PAI-1. Representative isotherms are shown for the titra-
tion of a active wild-type PAI-1, b latent wild-type PAI-1, c active 
H2AH3A PAI-1, d latent H2AH3A PAI-1 with Cu(II). Isotherms 
for the full data set for copper titration into active wild-type PAI-
1, including global fitting with replicates of four concentrations of 
Cu(II) titration solutions, are shown in Figure 2S. Isotherms for the 
full data set for copper titration into latent wild-type PAI-1, including 
global fitting for replicates of three concentrations of Cu(II) titration 
solutions, are shown in Figure 3S. Isotherms for the full data set for 
copper titration into active H2AH3A PAI-1, including global fitting 
for replicates of two concentrations of Cu(II) titration solutions, are 
shown in Figure 4S. Isotherms for the full data set for copper titra-
tion into latent H2AH3A PAI-1, including global fitting for replicates 
of two concentrations of Cu(II) titration solutions, are shown in Fig-
ure 5S. The data are baseline corrected in NITPIC software, and fit to 
a one-site binding model in SEDPHAT software. The data and fit are 
represented in GUSSI software via heats of injection (kcal mol−1) as 
a function of copper/PAI-1 molar ratio. Experiments were performed 
in triplicate
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of −27.0 kcal mol−1 (Fig. 5d, Figure 5S; Table 3). Similar 
to the active variant described above, the ΔHobs term for the 
latent H2AH3A PAI-1 is likely inaccurate. At this level of 
analysis, we consider the copper binding events to active and 
latent H2AH3A PAI-1 to be indistinguishable, where they 
both yield weak binding events with highly similar binding 
constants.
Discussion
Connecting copper binding to PAI‑1 and its functional 
stability as an active inhibitor
Hydrogen deuterium exchange measurements showed that 
copper binding to PAI-1 increases protein dynamics in 
regions relevant to the latency process [29]. PAI-1 lacking 
the N-terminal histidines retains the copper effects on pro-
tein dynamics, which are localized to the same regions as in 
wild-type PAI-1 [29]. This is further evidence that copper 
binding to the N-terminal domain cannot be solely respon-
sible for the accelerated latency transition, and that the other 
metal-binding site in PAI-1 may be involved in this process.
The goal of this study was to explore the effects that 
copper invokes on the stability of active PAI-1 [24, 33] as 
observed previously with the metal dependence in rates 
of the latency conversion and changes in dynamics [29]. 
The data collected for the H2AH3A variant of PAI-1 iden-
tified the histidine-rich, N-terminal region of PAI-1 to be 
involved in copper binding. A comparison of the properties 
of wild-type PAI-1 and the H2AH3A variant (summarized 
in Tables 1, 2, 3) establish that H2AH3A PAI-1 is more 
sensitive to latency conversion, and indeed converts faster 
in the presence of saturating levels of Cu(II) compared with 
wild-type PAI-1. Our ITC results demonstrate that there is 
a single, high-affinity Cu(II) binding site in active PAI-1 (Kd 
19 nM), whereas there are two copper-binding sites in latent 
PAI-1 (Kd values were measured to be 40 nM and 40 μM). 
Copper binding to the high affinity site in active PAI-1 was 
also characterized using stopped-flow kinetics, yielding a 
Kd ~90 nM [33] and demonstrating agreement between the 
two techniques. On the other hand, the gel-based copper 
titrations reveal “sensitivities” in latency conversion that can 
be attributed to the second, weaker copper binding site. Sub-
stitutions for the N-terminal histidines perturbed the high 
affinity copper binding site in active PAI-1, and this variant 
protein had an accelerated rate of latency.
Combining these results, we conclude that the high affin-
ity, N-terminal copper binding domain of PAI-1 plays a role 
in chelating free Cu(II) in solution, effectively protecting 
the active form of the protein, and the low affinity copper 
binding site promotes conversion to the latent form of PAI-1. 
Upon conversion from the active to the latent form, major 
structural changes occur in PAI-1, where two distinctive 
metal-binding sites are present. Structural differences in the 
latent form involve the insertion of the RCL into the central 
β-sheet, which displaces helices D and E in the flexible joint 
region and moves them away from the N terminus (Fig. 1). 
Based on the heat of Cu(II) coordination, it is likely that the 
latent form of PAI-1 contains different  copper−coordinating 
Table 3  Thermodynamic properties for Cu(II) binding to wild-type and H2AH3A PAI-1 at 10 °C
a Kd calculated from the following relationship: Kd = 1/Kobs
b ΔGobs calculated from ΔGobs = −RT ln Kobs
c −TΔSobs term calculated from ΔGobs = ΔHobs − TΔSobs
d Parameters measured at the low sensitivity limit of the ITC and likely have significant error associated with them
PAI-1 variant Model (n) [Cu(II)] Kobs,  M−1 Kda ΔGbobs, (kcal/mol) ΔHobs, (kcal/mol) −TΔScobs, (kcal/mol)
Active WT 1 650 µM 7.6 (±3.1) × 108 13 (±9) nM −10.2 (±0.3) −15.9 (±0.3) 5.7 (±0.3)
Active WT 1 700 µM 8.2 (±4.9) × 107 19 (±10) nM −10.0 (±0.7) −16.4 (±0.6) 6.3 (±0.7)
Active WT 1 750 µM 4.8 (±5.5) × 107 20 (±20) nM −9.9 (±0.4) −15.9 (±1.2) 5.0 (±1.2)
Active WT 1 800 µM 4.1 (±2.8) × 107 24 (±12) nM −9.8 (±0.2) −16.4 (±0.6) 6.5 (±0.6)
Latent WT 2 650 µM
High affinity
2.2 (±0.4) × 107 46 (±10) nM −9.5 (±0.1) −12.0 (±2.8) 2.5 (±0.1)
low affinity 4.20 (±2.8) × 104 24 (±12) μM −6.0 (±0.6) −11.2 (±3.0) 5.1 (±0.6)
Latent WT 2 750 µM
High affinity
2.6 (±0.7) × 107 38 (±10) nM −9.6 (±0.2) −12.0 (±2.9) 2.4 (±0.2)
Low affinity 2.9 (±1.1) × 104 35 (±12) μM −5.8 (±0.4) −11.2 (±3.1) 5.4 (±0.2)
Active H2AH3A 1 1200 µM 4.2 (±0.9) × 104 24 (±5) μM −6.0 (±0.1) −20.0 (±12.0)d 14 (±12)d
Active H2AH3A 1 1350 µM 2.7 (±2.1) × 104 37 (±12) μM −5.7 (±0.4) −51.6 (±13.0)d 46 (±13)d
Latent H2AH3A 1 1050 µM 5.2 (±4.0) × 104 19 (±15) μM −6.1 (±0.6) −37.5 (±11.0)d 31 (±11)d
Latent H2AH3A 1 1200 µM 7.7 (±4.6) × 104 13 (±6) μM −6.3 (±0.4) −16.4 (±0.6)d 10 (±0.4)d
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ligands to complement the N-terminal histidines and/or to 
comprise the second weaker site. In H2AH3A PAI-1, there 
is no high affinity site to bind adventitious Cu(II), which 
then leads this variant to sampling conformations more 
similar to the latent form which are ultimately highly sensi-
tive to copper. These differences affect the results collected 
for wild-type and variant forms of PAI-1 in the gel assays. 
Another possibility is that the high salt conditions used for 
the ITC experiments may disrupt copper binding to the 
weaker metal-binding site in the active protein. This notion 
is supported by the gel assays at matching salt concentra-
tions, in which the stability of wild-type or H2AH3A PAI-1 
was desensitized to Cu(II) over a broad concentration range 
(10 to >1000 μM). While specific disruption of the weaker 
metal-binding site is conceivable, the effect of higher ammo-
nium sulfate could also be a more general effect, consistent 
with the known effects of ammonium sulfate solutions on 
protein stabilization.
Copper coordination by the N‑terminal histidines 
stabilizes the PAI‑1/SMB complex
We have reported previously that wild-type PAI-1 in com-
plex with the SMB domain of VN is further stabilized by 
copper binding [24]; however, H2AH3A PAI-1 does not 
exhibit the synergistic effects of copper and SMB binding. 
Thus, it appears that Cu(II) binding to the N-terminal his-
tidines is responsible for the stabilizing effect of metal in 
combination with PAI-1 binding by the SMB domain. The 
stabilizing effects on PAI-1 that result from binding of the 
SMB domain alone are attributed to binding in the flexible 
joints region, resulting in widespread restriction of dynam-
ics, especially in nearby helices D, E, and F [28]. Copper 
binding to the PAI-1/SMB complex results in a restriction 
of dynamics near the N terminus of PAI-1, a phenomenon 
that does not occur in the absence of SMB domain [29]. This 
restriction of dynamics likely influences a local unfolding 
event on the proximal hA that occurs on a time scale relevant 
to the latency conversion process [30].
Conclusions
Copper binds to the N-terminal histidines of PAI-1 (H2, H3), 
but binding to this site does not result in accelerated latency 
in the presence of copper. In fact, binding of copper to this 
site stabilizes the active form of PAI-1. We propose that a 
second, low-affinity copper binding site is responsible for the 
copper-related destabilization of PAI-1. While this second 
site remains to be identified, it appears that the different 
structures of active and latent PAI-1 allow for alternative 
Cu(II) coordination sites. Potential Cu(II) binding residues 
near the N-terminal histidines in active PAI-1, including E81 
and H364, will be a focal point of future studies. Whether 
the weaker, destabilizing Cu(II)-coordination site represents 
an alternative binding mode in active PAI-1 or a distinct, 
independent site also must be a focal point of future studies. 
While the N-terminal histidines do not constitute the binding 
site that promotes the latency transition, this site is valuable 
in mediating the striking synergistic effects between cop-
per binding and the SMB domain. Interestingly, histidine-
rich, N-terminal copper- and nickel-binding domains have 
been recently identified in numerous proteins, but a specific 
role for these metal-binding motifs is unclear [50–53]. It is 
clear, however, that this N-terminal site in PAI-1 is critical 
because it appears to stabilize the active conformation of 
PAI-1 with SMB present when metal ions would otherwise 
quickly render PAI-1 in its latent form, which is ineffective 
as an inhibitor.
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